According to Ernst & Young, medical technology is one of the most innovative industries in the German economy, with total sales of around EUR 19 billion and a workforce of almost 100,000. The export rate is 65% and, despite the financial crisis, the sector is continuing to grow. Medical technology "made in Germany" enjoys an excellent reputation throughout the world. That is the conclusion of Heinrich Christen, partner and medtech expert at Ernst & Young Ltd in Zurich, who said: "German medical technology is innovative and successful all over the world, and Germany is still the biggest medtech player in Europe. Investors in Europe are committed to medical technology." He added that a high level of scientific and technical expertise was key to German suppliers succeeding on the market.
Over 60 guests took up the invitation to the Villa Eugenia in Hechingen on Wednesday, 28 April 2010. The hosts for the event were BioRegio STERN Management GmbH and the Medical Valley Hechingen Academy. Business people from the region's medtech sector, all keenly awaiting the presentation of the report, were impressed by the atmosphere of the unusual venue, which is also the headquarters of the Medical Valley Hechingen Academy. Hechingen's mayor Jürgen Weber praised the infrastructure for medtech research and manufacturing companies in the Medical Valley Hechingen and expressed his pleasure at being able to exclusively present the Medical Technology Report 2010.
Despite his words of praise, Christen was quick to point out that only global players are realistic contenders on the world market in the long term. He advised small and medium-sized companies to continue to hone their skills in areas of expertise and in particular to optimise their sales channels.
BioRegio STERN Management GmbH and the Medical Valley Hechingen Academy collaborated with the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb and MITT Centre of Competence for Minimally Invasive Medicine & Technology Tübingen-Tuttlingen on the presentation of the Medical Technology Report 2010. The accompanying talks by specialists from banks and investment companies shed light on medical technology from the perspective of the equity market, showed small and medium-sized companies ways of expanding their capital base and presented financing options for medtech innovations using venture capital.
Prof. Claus D. Claussen, Director of the Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb and of MITT, reserved special praise for companies and research institutes who had decided to cooperate in the form of research clusters. Dr. Klaus Eichenberg, Managing Director of BioRegio STERN Management GmbH, underlined the importance of medical technology as a cornerstone of the German economy and emphasised the enormous potential resulting from collaboration between the biotech and medtech sectors, which he promotes untiringly. "German medtech companies are currently well-positioned on the market, with many experiencing double-digit growth rates. Long may this continue."
Dr. Klaus EichenbergBioRegio STERN Management GmbHPhone: 0711-87 03 54 -0E-mail: info(at)bioregio-stern.de